Clinical Trial Update: A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case Finding

View source ↗

Summary

This cluster-randomized trial comparing DOTS to DOTS Plus active case finding for tuberculosis has completed. The snippet does not report trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Tuberculosis | Status: COMPLETED